Hjem › Prostatakreft › Wisconsin

Kliniske studier for Prostatakreft i Wisconsin

47 studier for Prostatakreft søker deltakere på steder i Wisconsin.

Byer i Wisconsin

Offisiell studietekst (engelsk)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Wisconsin Carbone Cancer Center, Madison

RekruttererFase 1/2

Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
og 25 flere

RekruttererFase 3

Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Froedtert Menomonee Falls Hospital, Menomonee Falls
Medical College of Wisconsin, Milwaukee
Froedtert and MCW Moorland Reserve Health Center, New Berlin
og 2 flere

RekruttererFase 3

Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
og 50 flere

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen

Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Marshfield Medical Center-Marshfield, Marshfield
Froedtert Menomonee Falls Hospital, Menomonee Falls
Medical College of Wisconsin, Milwaukee
og 2 flere

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06632977

PET/CT Characterization of Treatment Resistance

University of Wisconsin, Madison

Rekrutterer

Alder 18 og eldre · Menn · Oppdatert 1. okt. 2026 · NCT05647564

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Marshfield Medical Center-EC Cancer Center, Eau Claire
og 25 flere

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Medical College of Wisconsin ( Site 0020), Milwaukee

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

RekruttererFase 3

Alder 18 og eldre · Menn · Oppdatert 24. sep. 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Medical College Of Wisconsin, Milwaukee

RekruttererFase 2/3

Alder 18 til 100 · Menn · Oppdatert 22. sep. 2026 · NCT06780670

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Medical College of Wisconsin, Milwaukee

RekruttererFase 3

Alder 18 til 100 · Menn · Oppdatert 22. sep. 2026 · NCT06855277

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison

RekruttererFase 2

Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison

RekruttererFase 2

Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

University Hospital and UW Health Clinics ( Site 0065), Madison
Medical College of Wisconsin ( Site 0008), Milwaukee

RekruttererFase 3

Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT06925737

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Carbone Cancer Center University of Wisconsin-Madison, Madison

RekruttererFase 2

Alder 18 og eldre · Menn · Oppdatert 15. sep. 2026 · NCT06150417

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

University of Wisconsin, Madison

RekruttererFase 3

Alder 18 og eldre · Menn · Oppdatert 11. sep. 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Langlade Hospital and Cancer Center, Antigo
Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
og 36 flere

RekruttererFase 3

Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

Froedtert & the Medical College of Wisconsin, Milwaukee

RekruttererFase 2

Alder 18 og eldre · Menn · Oppdatert 9. sep. 2026 · NCT07226713

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

UW Health Carbone Cancer Center, Madison

RekruttererFase 2

Alder 18 og eldre · Menn · Oppdatert 3. sep. 2026 · NCT07005154

The Vanguard Study: Testing a New Way to Screen for Cancer

Zablocki Veterans Administration Medical Center, Milwaukee

RekruttererFrivillige helsepersonell ønskes velkommen

Alder 45 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06995898

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT06582017

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

University of Wisconsin Carbone Cancer Center, Madison

RekruttererObservasjonsstudie

Alder 18 og eldre · Menn · Oppdatert 27. aug. 2026 · NCT07050433

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

University of Wisconsin Carbone Cancer Center-Madison, Madison

RekruttererFase 2

Alder 18 og eldre · Menn · Oppdatert 21. aug. 2026 · NCT06844383

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Froedtert Hospital, Milwaukee

Rekrutterer

Alder 65 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07227077

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
Marshfield Medical Center-EC Cancer Center, Eau Claire
University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
og 13 flere

RekruttererFase 3

Alder 18 og eldre · Menn · Oppdatert 19. aug. 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Wisconsin, Carbone Cancer Center, Madison

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

University of Wisconsin Carbone Cancer Center, Madison
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee

RekruttererFase 1

Alder 18 til 100 · Menn · Oppdatert 13. aug. 2026 · NCT05519449

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

University of Wisconsin-Madison, Madison

RekruttererObservasjonsstudie

Alder 18 og eldre · Menn · Oppdatert 12. aug. 2026 · NCT04489719

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Medical College of Wisconsin, Milwaukee

RekruttererFase 1

Alder 18 og eldre · Menn · Oppdatert 31. jul. 2026 · NCT06613100

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Mayo Clinic Health System-Eau Claire, Eau Claire
Mayo Clinic Health System-Franciscan Healthcare, La Crosse

Rekrutterer

Alder 18 og eldre · Menn · Oppdatert 30. jul. 2026 · NCT06325046

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
Marshfield Medical Center-EC Cancer Center, Eau Claire
og 10 flere

RekruttererFase 3

Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

RekruttererFase 2

Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT05691465